Abiopharma

News list

Sanofi (SNY)

Event
July 28, 2022, 14:12 UTC

(30% Negative) Sanofi (SNY) Reports Q2 2022 Financial Results (Form 6-K)

Full text

News bot Oct. 18, 2025, 6:08 p.m.

🌍 Sanofi (SNY) - Form 6-K Filing

Filing Date: 2022-07-28

Accepted: 2022-07-28 10:12:37

Event Type: Financial Results

Event Details:

1 DocumentPress Release Strong execution in Q2 drives full-year 2022 guidance upgrade and delivers rich RD news flow in Immunology and Rare Disease Paris, July 28, 2022Q2 2022 sales growth of 8. 1 2 pressreleaseq22022english. 1% at CER driven by Dupixent, Rare Disease, Vaccines and CHCSpecialty Care grew 21.

📊 Key Financial Metrics (Year-over-Year Comparison):

Metric	2022	2021	Change ($)	Change (%)
Operating Income	1.54K	1.54K	$0.00	+0.00%
Net Income	1.21K	1.21K	$0.00	+0.00%
Assets	121.83K	120.24K	$1.58K	+1.32%
Cash	3.06K	3.18K	$-120.00	-3.77%

💼 Business Developments:

✅ Partnership/Collaboration
✅ Acquisition Activity
❌ Licensing Agreement: Not reported
✅ Regulatory Milestone
❌ Leadership Updates: Not reported

📞 Contact Information:

Email: sandrine.guendoul@sanofi.comSally